“…Antibodies-The following antibodies were used in this study: mouse monoclonal antibody (mAb) 337 specific for the 4 cytoplasmic domain of human AChR (30); mAb 268 specific for the ␣5 subunit of human AChR (J. Lindstrom); rat mAb 35, which immunoprecipitates ␣1, ␣3, and ␣5 AChR subunits (48,49); B3B9 anti-ERK-2 mouse mAb (a kind gift from M. Weber (50)); mouse mAb EC10 specific for residues [17][18][19][20][21][22][23][24][25][26][27] in the Unique domain of chicken c-Src (51); Q0, a pan-Src family rabbit polyclonal antibody raised against the C-terminal peptide (residues 522-533) of c-Src and reactive with c-Src, Fyn, c-Yes, and other SFKs (24,52); mouse mAb 2-17, reactive with residues 2-17 in the Unique domain of c-Src from all species (Quality Biotech, Camden, NJ); rabbit polyclonal anti-Fyn antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA); mouse mAb anti-c-Yes (Wako Industries, Japan); mouse mAb specific for human transferrin receptor (Zymed Laboratory Inc., South San Francisco, CA); and mouse mAb PY99 specific for phosphotyrosine (Santa Cruz). ChromPure mouse, rabbit, or rat IgGs (Jackson Laboratory) were used as species-matched, negative antibody controls.…”